Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study

Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study

Chronic-active antibody mediated rejection (caAMR) is the leading causes of long-term kidney graft failure. Tocilizumab (TCZ), an anti-IL-6 receptor antibody, has been suggested as a treatment, but data are conflicting. We retrospectively studied consecutive adult kidney transplant recipients with c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Johan Noble, Giorgia Comai, Valeria Corredetti, Reda Laamech, Celine Dard, Thomas Jouve, Diane Giovannini, Audrey Le Gouellec, Shivani Wadnerkar, Paolo Cravedi, Della Apuzzo, Daniele Vetrano, Marco Busutti, Chiara Abenavoli, Paolo Malvezzi, Lionel PE Rostaing, Gaetano Lamanna
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Transplant International
Subjects:	kidney transplantation tocilizumab microvascular inflammation donor-specific antibody chronic-active antibody-mediated rejection
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14502/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergoing Desensitization Therapy
by: Johan Noble, et al.
Published: (2024-07-01)

Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches
by: Johan Noble, et al.
Published: (2025-06-01)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
by: Hamza Naciri Bennani, et al.
Published: (2019-01-01)

Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept
by: Lara Cabezas, et al.
Published: (2024-06-01)

Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the Future
by: Johan Noble, et al.
Published: (2025-05-01)

Improved Tacrolimus Therapeutic Drug Monitoring in Kidney Transplantation: Optimizing an Old Drug Prescription
by: Johan Noble, et al.
Published: (2025-05-01)

Response to “A Caution Against the Use of C5B-9 Endothelial Assay to Support Eculizumab Therapy”
by: Federica Maritati, et al.
Published: (2024-05-01)

Response to Letter to the Editor From Bouwmeester RN et al.: “Eculizumab in Postransplant TMA: Unproven Benefit.”
by: Federica Maritati, et al.
Published: (2024-06-01)

Response to Letter to the Editor From Ville S. et al. About: “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-06-01)

Risk factors for IgA nephropathy recurrence and impact on graft survival in a cohort of kidney transplanted patients
by: Angelodaniele Napoletano, et al.
Published: (2025-12-01)

Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody
by: Joleen T. White, et al.
Published: (2024-12-01)

“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01)

Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
by: Romain Ollier, et al.
Published: (2023-12-01)

VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023-12-01)

Comparison of Torque Teno Virus DNA Load in Plasma and Whole Blood
by: Aurélie Truffot, et al.
Published: (2025-07-01)

Advancements in antibody-drug conjugates as cancer therapeutics
by: Jung Yin Fong, et al.
Published: (2025-08-01)

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Tuning antibody stability and function by rational designs of framework mutations
by: Joseph C. F. Ng, et al.
Published: (2025-12-01)

YAbS: The Antibody Society’s antibody therapeutics database
by: Puneet Rawat, et al.
Published: (2025-12-01)

The Application of Machine Learning on Antibody Discovery and Optimization
by: Jiayao Zheng, et al.
Published: (2024-12-01)

Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics
by: Marion Sallee, et al.
Published: (2024-09-01)

Human type I interferons protect Vero E6 and ARPE-19 cells against West Nile virus and are neutralized by pathogenic autoantibodies
by: Alessandro Ferrari, et al.
Published: (2025-04-01)

Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches
by: Sherif A. El-Kafrawy, et al.
Published: (2025-06-01)

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
by: Maria U. Johansson, et al.
Published: (2023-12-01)

Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01)

Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
by: Soma S.R. Banik, et al.
Published: (2023-12-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
by: Emanuele Andreano, et al.
Published: (2021-05-01)

Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen
by: Nathalie Chavarot, et al.
Published: (2025-03-01)

Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II
by: Kevin A. Henry, et al.
Published: (2024-12-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)

Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
by: Stefan Dübel
Published: (2024-12-01)

Research progress of antibody coupling technique in targeted drug delivery
by: Meng Li, et al.
Published: (2025-05-01)

Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01)

Understanding the Toxicity Profile of Approved ADCs
by: Pablo Ballestín, et al.
Published: (2025-02-01)

Prediction of Monoclonal Antibody Pharmacokinetics in Pediatric Populations Using PBPK Modeling and Simulation
by: Chiara Zunino, et al.
Published: (2025-07-01)

Viral and immune profiles during the first wave of SARS-CoV-2 infection in hospitalized patients in Sardinia, Italy
by: Giulietta Venturi, et al.
Published: (2025-02-01)

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
by: Marco Allinovi, et al.
Published: (2025-08-01)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
by: S. E. Sedykh, et al.
Published: (2019-01-01)